Your browser doesn't support javascript.
loading
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
Saleh, M N; Gutheil, J; Moore, M; Bunch, P W; Butler, J; Kunkel, L; Grillo-López, A J; LoBuglio, A F.
Affiliation
  • Saleh MN; University of Alabama at Birmingham, USA.
Semin Oncol ; 27(6 Suppl 12): 99-103, 2000 Dec.
Article in En | MEDLINE | ID: mdl-11226008
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Semin Oncol Year: 2000 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Semin Oncol Year: 2000 Document type: Article Affiliation country: